CARD, the Center for Autism and Related Disorders, Inc., has conducted a double-blind placebo-controlled trial which found that HBOT, consisting of 24% oxygen delivered at 1.3 atmospheres of pressure, does not have a significant effect on symptoms of autism. The study is summarized on the CARD blog.
autism
0 التعليقات:
إرسال تعليق